{
    "clinical_study": {
        "@rank": "131142", 
        "arm_group": [
            {
                "arm_group_label": "DHA,VITAMIN E, CHOLINE", 
                "arm_group_type": "Experimental", 
                "description": "DHA, VITAMIN E AND CHOLINE BY MOUTH EVERY DAY FOR 12 MONTHS"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "placebo and lifestyle intervention [hypocaloric Diet (25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity]."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this interventional study is to evaluate the efficacy and tolerability of\n      docosahexaenoic acid (DHA), Vitamin E and Choline in children or adolescents with\n      well-characterized and liver biopsy confirmed nonalcoholic fatty liver disease (NAFLD)."
        }, 
        "brief_title": "EFFICACY AND TOLERANCE OF TREATMENT WITH DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Fatty Liver", 
            "Liver Fibrosis", 
            "Obesity", 
            "Metabolic Syndrome", 
            "Nonalcoholic Fatty Liver Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fatty Liver", 
                "Fibrosis", 
                "Liver Diseases", 
                "Obesity", 
                "Liver Cirrhosis", 
                "Metabolic Syndrome X"
            ]
        }, 
        "detailed_description": {
            "textblock": "Sixty children or adolescents (4-16 years) with liver biopsy proven NAFLD will be enrolled.\n      They will be randomized to treatment with DHA, VIT E and Choline (n=30)or an identical\n      placebo (n=30) given orally for a period of 12 months. All patients will be included in a\n      lifestyle intervention program consisting of a diet tailored on the individual requirements\n      and physical exercise.\n\n      Patients will undergo a medical evaluation every three months during the 12-month study\n      period. Liver biopsy will be performed only at baseline  Anthropometric analysis, laboratory\n      tests, including liver enzymes and lipids will be repeated at 3-month intervals during the\n      12-months study duration. Ultrasonographyof the liver will be repeated after six months at\n      the end of the study period."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  persistently elevated serum aminotransferase levels\n\n          -  diffusely echogenic liver on imaging studies suggestive of fatty liver\n\n          -  biopsy consistent with the diagnosis of NAFLD\n\n        Exclusion Criteria:\n\n          -  hepatic virus infections (HCV RNA-PCR negative)\n\n          -  Hepatitis A, B, C, D, E and G\n\n          -  cytomegalovirus and Epstein-Barr virus\n\n          -  alcohol consumption\n\n          -  history of parenteral nutrition\n\n          -  use of drugs known to induce steatosis or to affect body weight and carbohydrate\n             metabolism\n\n          -  autoimmune liver disease, metabolic liver disease, Wilson's disease, and\n             a-1-antitrypsin-associated liver disease were ruled out using standard clinical,\n             laboratory and histological criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "16 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01934777", 
            "org_study_id": "OPBG-DHA, VIT E, CHOLINE"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "DHA,VITAMIN E, CHOLINE", 
                    "placebo"
                ], 
                "description": "DHA, Vitamin E and Choline plus lifestyle intervention [hypocaloric Diet (25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity].", 
                "intervention_name": "Docosahexaenoic Acid, Vitamin E,  choline", 
                "intervention_type": "Drug", 
                "other_name": "Docosahexaenoic Acid, Alpha tocopherol, choline"
            }, 
            {
                "arm_group_label": [
                    "DHA,VITAMIN E, CHOLINE", 
                    "placebo"
                ], 
                "description": "placebo and lifestyle intervention [hypocaloric Diet (25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity].", 
                "intervention_name": "placebo", 
                "intervention_type": "Drug", 
                "other_name": "placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Choline", 
                "Vitamin E", 
                "Alpha-Tocopherol", 
                "Tocopherols", 
                "Tocotrienols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "NAFLD", 
            "NASH", 
            "fibrosis"
        ], 
        "lastchanged_date": "August 30, 2013", 
        "location": {
            "contact": {
                "email": "nobili66@yahoo.it", 
                "last_name": "Valerio Nobili, MD", 
                "phone": "06/68592192"
            }, 
            "facility": {
                "address": {
                    "city": "Rome", 
                    "country": "Italy", 
                    "state": "Rome, Italy", 
                    "zip": "00165"
                }, 
                "name": "Bambino Ges\u00f9 Hospital and Research Institute"
            }, 
            "investigator": {
                "last_name": "Valerio Nobili, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "STUDY OF EFFICACY AND TOLERANCE OF TREATMENT WITH DHA, Choline and Vitamin E in Children With Non-alcoholic Steatohepatitis", 
        "other_outcome": {
            "measure": "Serum levels of triglycerides", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "overall_contact": {
            "email": "nobili66@yahoo.it", 
            "last_name": "Valerio Nobili, MD"
        }, 
        "overall_official": {
            "affiliation": "Bambino Ges\u00f9 Children Hospital", 
            "last_name": "Valerio Nobili, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Liver status (steatosis and fibrosis) by ultrasonographic and fibroscan", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01934777"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Bambino Ges\u00f9 Hospital and Research Institute", 
            "investigator_full_name": "Valerio Nobili", 
            "investigator_title": "Head of Hepato-Metabolic Disease Unit, Bambino Ges\u00f9 Children Hospital, IRCCS", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Serum alanine transferase levels", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "source": "Bambino Ges\u00f9 Hospital and Research Institute", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bambino Ges\u00f9 Hospital and Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}